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OBJECTIVE — Hypoglycemia is associated with adverse outcomes in mixed populations of
patients in intensive care units. It is not known whether the same risks exist for diabetic patients
whoarelessseverelyill.Inthisstudy,weaimedtodeterminewhetherhypoglycemicepisodesare
associated with higher mortality in diabetic patients hospitalized in the general ward.
RESEARCH DESIGN AND METHODS — This retrospective cohort study analyzed
4,368 admissions of 2,582 patients with diabetes hospitalized in the general ward of a teaching
hospital between January 2003 and August 2004. The associations between the number and
severity of hypoglycemic (50 mg/dl) episodes and inpatient mortality, length of stay (LOS),
and mortality within 1 year after discharge were evaluated.
RESULTS — Hypoglycemia was observed in 7.7% of admissions. In multivariable analysis,
each additional day with hypoglycemia was associated with an increase of 85.3% in the odds of
inpatient death (P  0.009) and 65.8% (P  0.0003) in the odds of death within 1 year from
discharge. The odds of inpatient death also rose threefold for every 10 mg/dl decrease in the
lowest blood glucose during hospitalization (P  0.0058). LOS increased by 2.5 days for each
day with hypoglycemia (P  0.0001).
CONCLUSIONS — Hypoglycemia is common in diabetic patients hospitalized in the gen-
eralward.PatientswithhypoglycemiahaveincreasedLOSandhighermortalitybothduringand
after admission. Measures should be undertaken to decrease the frequency of hypoglycemia in
this high-risk patient population.
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I
n recent years, there has been an in-
creasingfocusoncontrollinghypergly-
cemia in hospitalized patients (1).
Hyperglycemia is associated with adverse
clinical outcomes, and randomized con-
trolledtrialsinintensivecareunits(ICUs)
have shown that aggressive treatment of
elevated blood glucose improves out-
comes. Tight glucose control, however, is
not without risk. Studies have suggested
that the beneﬁts of tight glycemic control
may be at least partially offset by the in-
creased risk of hypoglycemia (2,3). In
particular, hypoglycemia in ICUs has
been linked to increased risk of mortality,
seizures, and coma (4).
It remains unknown whether the
risksassociatedwithhypoglycemiafound
in critically ill patients can be generalized
to non-ICU settings. The etiology of hy-
poglycemiainICUpatientsmaybediffer-
ent from that in patients hospitalized in
thegeneralward.Anumberofriskfactors
for hypoglycemia in critically ill patients,
including continuous venovenous hemo-
ﬁltration, inotropic support, or sepsis are
absentorlesscommonoutsideoftheICU
(5).
It also remains unknown whether re-
portedrisksofhypoglycemiainICUstud-
ies,whichincludedprimarilynondiabetic
patients, also apply to patients with
known diabetes. Several studies have
demonstrated that the relationship of ele-
vated blood glucose with clinical out-
comes may be quantitatively and
qualitatively different between patients
with and without a diagnosis of diabetes.
Hyperglycemic patients with diabetes
have been found to have lower mortality
than nondiabetic hyperglycemic patients;
they may also derive less or no beneﬁt
from intensive glycemic control (3,6–
10).Itispossiblethatasimilardivergence
exists for hypoglycemia as well.
Because the majority of hospitalized
patients with diabetes are treated in the
general ward, it is important to under-
stand the relationship of hypoglycemia in
diabetic patients in the general ward with
clinical outcomes. To this end, we exam-
ined whether hypoglycemia in patients
with diabetes hospitalized in the general
wardisassociatedwithadverseoutcomes.
We assessed the relationship between the
number and severity of hypoglycemic ep-
isodes with in-hospital mortality and the
length of hospital stay. We also evaluated
the association between hypoglycemia
and outpatient mortality 1 year after
discharge.
RESEARCH DESIGN AND
METHODS— We conducted a retro-
spective cohort study to investigate
whether hypoglycemia in diabetic pa-
tients hospitalized in the general ward is
associated with poor clinical outcomes.
We evaluated the relationship between 1)
the number of days with hypoglycemia
(predictor variable) during the hospital
admission and 2) hospital mortality (pri-
mary outcome variable). We also con-
ducted three secondary analyses: 1) the
relationship between a) the lowest re-
corded blood glucose and b) hospital
mortality; 2) the relationship between a)
the number of days with hypoglycemia
and b) outpatient mortality within 1 year
from discharge; and 3) the relationship
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poglycemia and b) the change from the
length of stay (LOS) expected based on
the diagnosis-related group (DRG). The
institutional review board at Partners
HealthCare approved the study and
waived the need for informed consent.
Study patients and settings
Patientswithdiabeteswhowereadmitted
to a 734-bed teaching hospital between
January 2003 and August 2004 were
studied.Patientswithdiabeteswereiden-
tiﬁed through a combination of computa-
tional analysis of the text of their
physician notes with billing and labora-
tory data using a previously validated al-
gorithm. When compared with a manual
record review, the algorithm has a sensi-
tivity of 96.2% and a speciﬁcity of 98.0%
(11).Pregnantwomenandnewborns,pa-
tients who had stayed in an ICU during
theirhospitalization,patientswhohadre-
ceived intravenous total parenteral nutri-
tion, and patients for whom point-of-care
blood glucose results were not available
were excluded from the analysis.
Outcome and exposure measures
Hypoglycemia was deﬁned as blood glu-
cose 50 mg/dl. Only point-of-care
blood glucose levels were used in the
analysis. Changes from the expected
length of hospital stay were computed as
thedifferencebetweentheactualLOSand
the mean LOS for the patient’s DRG (12).
A modiﬁed Charlson Comorbidity Index
was computed using administrative bill-
ingcodes(13)excludingdiabetesbecause
all study subjects had this diagnosis. Pa-
tient-day weighted mean blood glucose
during the hospital stay was calculated as
the mean of all blood glucose readings on
a single day averaged over the course of
the hospital stay (14). Glomerular ﬁltra-
tion rate (GFR) was calculated using the
modiﬁcation of diet in renal disease for-
mula (15). An elevation in liver function
test results was quantiﬁed as the average
of the fold difference of alanine amino-
transferase and aspartate aminotransfer-
ase levels over the upper limit of normal.
Normal values were imputed in place of
missinglaboratorydata.Complicationsof
diabetes (nephropathy, neuropathy, oph-
thalmopathy,andperipheralvasculardis-
ease) were ascertained from the ICD-9
billing codes reported for each patient up
to the end of the study period. One inpa-
tient or two outpatient billing codes were
required to conﬁrm each diagnosis.
Data sources
Patient demographics, dates of death, ad-
mission and discharge dates, laboratory
data, billing codes, discharge summaries,
and outpatient physician notes were ob-
tained from the Research Patient Data
Registry, a large data warehouse that
serves as a central clinical data repository
for participating hospitals and clinics
within the Partners HealthCare System.
Computerized Physician Order Entry
data were obtained from the hospital in-
patient electronic health record. Point-of-
care blood glucose data were obtained
from the QC Manager system (Abbott
Laboratories, Abbott Park, IL).
Statistical analysis
Summary statistics were constructed by
usingfrequenciesandproportionsforcat-
egorical data and by using means, SDs,
and medians and ranges for continuous
variables. Summary statistics for patient
demographics (age, sex, ethnicity, and
health insurance) were calculated for in-
dividual patients. The remainder of the
summary statistics were calculated for in-
dividual hospital admissions. Analysis of
the outpatient mortality within 1 year
from discharge was limited to the last ad-
mission during the study period for each
unique patient. The univariate associa-
tions between the number of days with
hypoglycemic episodes and clinical out-
comes (inpatient mortality, mortality
within 1 year after discharge, and length
of hospital stay) were assessed using a
Wilcoxon test for continuous variables
andFisher’sexacttestforbinaryvariables.
To account for clustering within indi-
vidual patients and to adjust for other co-
variates, a hierarchical (multilevel)
multiple logistic regression model for the
probability of inpatient death was con-
structed using a generalized estimated
equation approach. A similar model was
used for the analysis of the outpatient
death within 1 year from discharge date
includingonlythelasthospitaladmission
during the study period for each patient.
To determine the relationship be-
tween the number of days with hypogly-
cemic events and the length of hospital
stay, we constructed a hierarchical (mul-
tilevel) multivariable mixed linear regres-
sion model with random effects to
account for clustering within individual
patients. Random cluster effects were
used to generate the correlation structure
for intracluster observations and to ac-
count for individual patient effect levels.
All multivariable models included patient
age, sex, ethnicity, health insurance, pa-
tient-day weighted mean blood glucose
during hospital stay, length of hospital
stay expected based on the DRG, and
modiﬁed Charlson Comorbidity Index as
covariates.Pvalues were obtained using a
type III test for all multivariable analyses.
Signiﬁcance thresholds were adjusted for
multiple hypothesis testing using the
Simes-Hochberg method (16,17). All
analyses were performed with SAS statis-
tical software (version 9.1; SAS Institute,
Cary, NC).
RESULTS
Hypoglycemia in hospitalized
diabetic patients
We identiﬁed 5,190 admissions of pa-
tients with diabetes (excluding pregnant
women and newborns) that took place
between January 2003 and August 2004
and had point-of-care blood glucose test-
ing results. Of these patients, 785 had
stayed in an ICU during their hospitaliza-
tion, and 37 received total parenteral nu-
trition. These 822 admissions were
excluded from the analysis.
The ﬁnal analytical dataset included
4,368 admissions of 2,582 unique pa-
tients. Median age at the time of admis-
sion was 66 years and median modiﬁed
Charlson Comorbidity Index was 5 (Ta-
ble 1). Most patients had sliding scale in-
sulin ordered, and 2,700 (61.8%)
received scheduled antihyperglycemic
medications (either insulin or oral). Hy-
poglycemic events (blood glucose 50
mg/dl) were documented in 338 (7.7%)
admissions. The average blood glucose
level (measured using point-of-care test-
ing) during a hypoglycemic episode was
41 mg/dl. Severe hyperglycemia (300
mg/dl) was observed for 1,272 (29.1%)
admissions, and in 169 (3.9%) admis-
sions there were both severe hyperglyce-
mia and hypoglycemia documented. In
multivariable analysis the odds of a hypo-
glycemic episode increased by 2.5-fold
for patients receiving scheduled insulin
(P  0.0001). Complications of diabetes
and other comorbidities, GFR, liver func-
tion test abnormalities, and patient age
were not associated with a change in risk
for a hypoglycemic episode.
Frequency of hypoglycemia and
patient mortality
In univariate analysis, inpatient mortality
was 2.96% for patients who had at least
one hypoglycemic episode during the
hospital stay vs. 0.82% for patients who
Hypoglycemia and inpatient outcomes
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analysis adjusted for the patients’ demo-
graphics, expected LOS, Charlson Co-
morbidity Index, GFR, complications of
diabetes, and average blood glucose, the
odds of inpatient mortality rose by 85.3%
for each additional day with a hypoglyce-
mic episode (P  0.009). The odds of
inpatient mortality also increased by
24.8% for each additional point of the
Charlson Comorbidity Index (P 
0.0001). Patient age, GFR, and insulin
secretagogue use during the admission
had no signiﬁcant relationship with inpa-
tient mortality.
Mortality 1 year after discharge was
27.8% for patients who had at least one
hypoglycemic episode vs. 14.1% for pa-
tientswhohadnohypoglycemicepisodes
(P0.0001).Univariateanalysisshowed
a progressive increase in 1-year mortality
from 14.1%for patients with no hypogly-
cemicepisodesto33.3%forpatientswith
more than two hypoglycemic episodes
(Fig. 1). Multivariable analysis of this
dataset showed a 65.8% increase in mor-
tality 1 year after discharge for each day
with a hypoglycemic episode during the
admission (P  0.0003) and a 41.8% de-
crease for patients given insulin secreta-
gogues during their hospitalization (P 
0.0007).
Degree of hypoglycemia and patient
mortality
In univariate analysis of a subset of 338
admissions for which any hypoglycemia
was documented, the mean lowest re-
corded blood glucose was 31.8 mg/dl for
patients who died in the hospital vs. 40
mg/dl for those who did not (P  0.028).
Inpatient mortality rate increased pro-
gressively from 1.9% for patients whose
lowest blood glucose was 39 mg/dl to
8.2% for those with lowest glucose 30
mg/dl (Fig. 2). In multivariable analysis,
the odds of inpatient mortality increased
threefold for every 10 mg/dl decrease in
the lowest blood glucose (P  0.0058).
There was no signiﬁcant relationship be-
tween the degree of hypoglycemia and
mortality at 1 year after discharge.
Hypoglycemia and length of
hospitalization
Inunivariateanalysis,patientswhohadat
least one episode of hypoglycemia stayed
in the hospital 2.8 days longer than pa-
tientswhodidnothaveanyhypoglycemic
episodes(P0.0001).Thedifferencebe-
tween actual LOS and LOS expected for
the DRG increased gradually from –1.0
daysforpatientswithnohypoglycemiato
8.8 days for patients with 2 days with a
hypoglycemic episode (Fig. 3).
In a multivariable analysis adjusted
for the patients’ demographics, expected
LOS, Charlson Comorbidity Index, dia-
betes complications, GFR, and average
blood glucose, the actual length of stay
Figure 1—Frequency of hypoglycemia and 1-year mortality. Bars indicate 95% CI. The number
of admissions in each category is given in parentheses.
Table 1—Patient characteristics
Total study admissions 4,368
Unique subjects 2,582
Mean age (years)* 63.6  15.1
Female sex 1,325 (51.3)
Ethnicity
White 1,517 (58.8)
Black 544 (21.1)
Hispanic 273 (10.6)
Other/unknown 248 (9.6)
Insurance
Medicare 1,428 (55.3)
Medicaid 332 (12.6)
Commercial 800 (31.0)
Self-pay 22 (0.9)
Admission service
Medical 2,702 (61.9)
Surgical 1,660 (38.0)
Unknown 6 (0.1)
Glomerular ﬁltration rate (ml/min) 64.6  38.4
Mean modiﬁed Charlson Comorbidities Index† 4.9  3.3
Received sliding-scale insulin 3,479 (79.6)
Received scheduled insulin 1,427 (32.7)
Received oral antihyperglycemic agents 1,530 (35.0)
Received insulin secretagogues 1,069 (24.5)
Actual LOS (days) 4.9  5.5
Deviation from DRG-based LOS (days) 0.8  5.0
Mean blood glucose (mg/dl)‡ 168.8  48.0
Mean days with hypoglycemia 0.1  0.41
Deceased during the admission 43 (1.0)
Deceased within a year from discharge§ 388 (17.9)
Dataaren,n(%),ormeansSD.Aggregatepatient-levelcharacteristics(e.g.,demographics)werecalculated
attheindividualpatientlevel,andaggregateadmission-levelcharacteristics(e.g.,LOS)werecalculatedatthe
individual admission level. *At the time of the ﬁrst study admission. †Diabetes was excluded from the
computation of the index. ‡Patient-day weighted mean glucose level. §Calculated for the last study period
admission of the 2,582 unique study patients.
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average for the DRG for each additional
day with a hypoglycemic episode (P 
0.0001). LOS also increased by 0.14 days
for each additional point of the Charlson
Comorbidity Index. There was no signif-
icant relationship between the lowest
blood glucose level during the admission
and the length of the hospital stay.
CONCLUSIONS — In this large ret-
rospectivecohortstudyof4,000admis-
sions, we have focused on patients with
known diabetes admitted to the general
hospital ward. Mortality among hypogly-
cemic patients in this population was 3%,
signiﬁcantly lower than the 22–48% ob-
served in the previously published inves-
tigations that included critically ill
patients (18–21). Nevertheless, we have
found a similarly strong relationship be-
tweenhypoglycemiaandin-hospitalmor-
tality as well as LOS. Unlike in some
studies of the general hospital population
(18,20), this relationship was dose de-
pendent: both LOS and inpatient mortal-
ity increased gradually as the number of
hypoglycemicepisodesrose.Agreaterde-
gree of hypoglycemia was also associated
with an increase in inpatient mortality.
Furthermore, an analysis of a data subset
thatcontainedonlyoneadmissionperpa-
tient revealed a strong association be-
tween the number of episodes of
hypoglycemia and outpatient mortality at
1 year after discharge from the hospital.
Although the retrospective nature of
our analysis does not allow a direct infer-
ence of causality, several explanations of
thisrelationshipcanbehypothesized.On
the one hand, hypoglycemia could affect
outcomes directly by leading to falls, sei-
zures, or death. It could also have an in-
direct effect by requiring adjustments of
the patients’ antihyperglycemic regimen
or delays of tests and procedures, conse-
quently leading to an extension of the
hospital stay.
On the other hand, hypoglycemia
could be a marker for disease severity.
Studies in the general hospital popula-
tion, including patients in the ICU,
showed that decreased caloric intake,
which could be related to disease-
induced anorexia, was a signiﬁcant con-
tributor to hypoglycemia (5,18).
Although our study design excluded crit-
ically ill patients, malnutrition is well de-
scribed in less severely ill patients as well
(22). The marker hypothesis is further
supported by the strong association be-
tween hypoglycemia and outpatient mor-
tality, a ﬁnding that is difﬁcult to explain
by a direct effect of inpatient hypoglyce-
mia on survival.
Several recommendations can be
made on the basis of our results. Sicker
diabetic patients in the general ward
should be monitored closely for the oc-
currence of hypoglycemia. Extra care
should be taken to prevent hypoglycemic
events in this population already at high
risk for adverse events, with particular at-
tention being paid to matching the anti-
hyperglycemic regimen to the nutritional
intake. At the same time, hypoglycemia
among diabetic patients in the general
ward could be interpreted as a warning
sign of an impending clinical deteriora-
tion. It could therefore serve as a useful
indicator for the necessity of increased
monitoring, more aggressive treatment of
infections, transitioning to a more inten-
sive care setting, and case management.
Our study has a number of strengths.
It is the ﬁrst study to focus on patients
with diabetes hospitalized in the general
ward, by far the largest group of inpa-
tients at high risk for hypoglycemia. It is
oneofthelargestanalysesofthephenom-
enon of inpatient hypoglycemia, encom-
passing 4,300 admissions of 2,582
individual patients. In addition, it in-
cludedbothinpatientandoutpatientout-
comes, thus helping to differentiate
Figure 2—Lowest blood glucose and inpatient mortality. The lowest blood glucose level recorded
duringthehospitalstaywasplottedagainstthefractionofpatientswhodiedduringtheadmission
for 338 patients who had at least one hypoglycemic episode documented in the hospital. Bars
indicate 95% CI. The number of admissions in each category is given in parentheses.
Figure 3—Frequency of hypoglycemia and length of hospital stay. Bars indicate SEM. The
number of admissions in each category is given in parentheses.
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mia from a noncausal association.
This analysis has several limitations.
The study included only patients admit-
ted to a single academic hospital in Bos-
ton, Massachusetts, which could limit its
generalizability to other geographic and
health care settings. It was impossible to
differentiate between type 1 and type 2
diabetes from the available data; there-
fore, it cannot be stated with certainty
whetherourﬁndingsapplytooneorboth
conditions. However, statistically, most
patients in the hospital have type 2 diabe-
tes. Lack of nutrition information for in-
dividual patients has hindered the
analysis of the causes of hypoglycemia.
Furthermore,ourdatadidnotincludede-
scriptions of the types and severity of the
immediate clinical sequelae (changes in
mental status, loss of consciousness, or
seizures) of the hypoglycemic episodes.
We used point-of-care blood glucose lev-
els in this study, the accuracy of which
may have been limited, particularly at the
lower glucose levels. On the other hand,
central laboratory glucose levels used in
many other studies are typically obtained
much less frequently, possibly leading to
an underestimation of the frequency and
severityofhypoglycemia.Inaddition,un-
less blood samples for glucose measure-
ment are routinely collected into tubes
with a glycolysis inhibitor, the measured
blood glucose level may be falsely low-
ered in patients with high white cell
counts (23), precisely the patients at high
riskforadverseoutcomes.Finally,theret-
rospective nature of the study does not
allowustodrawconclusionsaboutcausal
relationships and may have led to a bias if
missing data were distributed unevenly
with respect to the outcomes analyzed.
In summary, hypoglycemia in dia-
betic patients hospitalized in the general
ward was associated with increased inpa-
tient and postdischarge mortality as well
as with a prolonged LOS. Further studies
are needed to establish a causal relation-
ship. In the meantime, care should be
taken to prevent hypoglycemia in this
high-risk patient population.
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